SHL Telemedicine 2025 half-year update, capital raise

SHL Telemedicine Ltd. furnished a Form 6-K highlighting a September 11, 2025 press release that presents its 2025 half-year results and states that the company targets a capital raise.

Accepted by SEC EDGAR 09/11/2025 - 06:00 AM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

SHL Telemedicine Ltd. furnished a Form 6-K highlighting a September 11, 2025 press release that presents its 2025 half-year results and states that the company targets a capital raise. The press release also includes forward-looking statements along with cautionary language about factors that could cause actual results to differ.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SHL Telemedicine Ltd. (SHLT) report in its September 2025 Form 6-K?

SHL Telemedicine reported that it issued a press release on September 11, 2025 presenting its 2025 half-year results and targeting a capital raise. The report furnishes this release as an exhibit and incorporates it by reference for investors.

Does SHL Telemedicine’s September 2025 update mention a capital raise?

Yes. SHL Telemedicine states in the September 11, 2025 press release that it targets a capital raise. The Form 6-K notes this objective while furnishing the release as an exhibit for additional detail on the company’s plans.

What time period do SHL Telemedicine’s latest results in this update cover?

The company’s press release discusses its 2025 half-year results. This means it summarizes performance for the first half of 2025, with the Form 6-K simply referencing and furnishing that release rather than repeating the detailed figures.

What risk disclosures accompany SHL Telemedicine’s 2025 half-year results announcement?

The company notes that the press release contains forward-looking statements and includes cautionary statements. These cautionary statements highlight important factors that could cause actual results to differ materially from the projections or expectations expressed.

When was SHL Telemedicine’s 2025 half-year results press release issued?

The press release was issued on September 11, 2025. The Form 6-K filed by SHL Telemedicine furnishes this release as Exhibit 99.1 and incorporates its contents by reference as part of the company’s official disclosure record.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-41641

SHL TELEMEDICINE LTD.

(Translation of registrant’s name into English)

90 Yigal Alon Street

Tel Aviv 67891, Israel

(Address of principal executive offices)

_____________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

On September 11, 2025, SHL Telemedicine Ltd. (the “Company”) issued a press release titled “SHL announces 2025 half-year results and targets a capital raise”, a copy of which is furnished herewith as Exhibit 99.1, and which is incorporated by reference herein. The press release contains forward-looking statements and includes cautionary statements identifying important factors that could cause actual results to differ materially from those in the forward-looking statements.

EXHIBIT INDEX

Exhibit

Description

99.1	Press release, dated September 11, 2025, titled “SHL announces 2025 half-year results and targets a capital raise”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SHL TELEMEDICINE LTD.

	By:	/s/ Lior Haalman
		Lior Haalman
		Chief Financial Officer

September 11, 2025

Source: View Original Filing on SEC EDGAR